Medicine

Hibernation science took advantage of to address excessive weight as well as modify metabolism

.Attribute Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recognizin...

CAR- T as well as cellular genetics therapies are also costly

.Mother Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of...

The WHO genomics plan of work with nondiscriminatory execution of individual genomics for worldwide health

.The publication of the initial draft of the human genome series in 20011 was actually followed by t...

A time-stratified, case\u00e2 $ \"crossover research of heat visibility as well as perinatal death from 16 health centers in sub-Saharan Africa

.Among 138,015 hospital-based singleton births in 4 sub-Saharan African countries, our experts obser...

Advancing international antibiotic analysis, growth and accessibility #.\n\nMurray, C. J. L. et al. Worldwide burden of microbial antimicrobial protection in 2019: a systematic review. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of details devotions as well as action in the reaction to antimicrobial protection. Worldwide Leaders Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Health And Wellness Institution. WHO posts listing of germs for which new antibiotics are quickly needed. Globe Health and wellness Institution https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health Organization. WHO microbial priority microorganisms listing, 2024: microbial virus of hygienics value to direct research, development and strategies to avoid as well as handle antimicrobial protection. World Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative access. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nWorld Health And Wellness Organization. 2023 anti-bacterial agents in medical and also preclinical progression: a summary and review. Planet Wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Assessment. May 19, 2016 \u00e2 $\" Handling drug-resistant diseases globally: final record as well as recommendations. Customer Review on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outcomes: reports as well as rundown. Drive AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall: a require concurrent action on anti-biotics experimentation. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Quick 51: How can the EU support sustainable development and accessibility to reliable antibiotics? plan alternatives for existing as well as brand-new medicines. European Observatory on Health Systems as well as Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic make use of as well as resistance\u00e2 $\" proving the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Association. 2021 Mindful distinction. WHO access, view, reserve, category of prescription antibiotics for examination as well as monitoring of making use of. World Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Center for Illness Deterrence and Management. Antimicrobial protection aim ats: just how can our company reach all of them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Planet Health And Wellness Company. Absence of technology set to undermine antibiotic functionality and also health gains. Globe Wellness Company https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. How antimicrobial resistance is connected to temperature improvement: a summary of pair of linked international difficulties. Int. J. Environ. Res. Public Health twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: we require emergency action and also expenditure that pay attention to the weakest hyperlink. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Wellness Company. Immunization protection. World Wellness Organization https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection deterrence as well as management in low-resource environments: the necessity for the regional, the contextual and the practical. Contaminate. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of implementing antimicrobial stewardship devices in reduced to mid profit nations (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A brief background of the antibiotic time: sessions found out and difficulties for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et cetera. Person access in 14 high-income countries to new antibacterials approved due to the United States Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals and also Medical Devices Agency, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Company. 2021 anti-bacterial agents in medical and also preclinical growth: an outline and analysis. Planet Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Anti-biotics: the business economics have to support the science. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of advancement in antibacterial therapies. Medical Development Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Determining specialist application of next-generation prescription antibiotics against resisting Gram-negative contaminations in U.S. healthcare facilities: a retrospective cohort study. Ann. Intern. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of technology in antibacterial therapies. Medical Technology Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic customer review as well as essential examination of reward techniques for exploration and progression of unfamiliar antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth And Wellness Unexpected Emergency Readiness as well as Response Authority. Trial and error of clinical countermeasures. International Compensation https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Payment. Pre-draft plan for an European partnership under Horizon Europe One Health And Wellness Antimicrobial Protection. European Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Worldwide Prescription Antibiotic R &amp D Partnership. Entasis Therapeutics and the Global Antibiotic Research &amp Development Partnership to establish a brand new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of sector- and non-industry-sponsored scientific trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Organization. Amount of clinical test signs up through location, ailment, stage of advancement, grow older and sex of trial individuals (1999\u00e2 $ \"2022). World Health and wellness Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Anti-biotic R &amp D Partnership. NeoSept1: a research study to identify the ranking of existing as well as brand new antibiotics blends to deal with newborn babies that reside in health center with serious blood poisoning. ISRCTN registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Company of Canada. Authorities of Canada brings in crucial financial investment to overcome antimicrobial protection (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Worldwide Anti-biotic Trial And Error Relationship. Japan federal government funding assists GARDP\u00e2 $ s attempts to resist antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Foundation. Novo Nordisk Base partners along with CARB-X to overcome drug-resistant infections. novo nordisk base https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health and also Digital Manager Organization. Study on delivering AMR medical countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Approximating the necessary size of international pull incentives for antibacterial medicines. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimension a market entry reward for the advancement of brand new prescription antibiotics. Harvard Kennedy University https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Business rewards and also antibiotic protection: an intro to the antibiotic susceptibility incentive. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. A determined USG progressed dedication for subscription-based investing in of novel antimicrobials and its expected roi. Center for Global Growth https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 financial investments in brand-new antibiotics will pay \u00e2 $\" for everyone. Office of Health Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts war against lethal contaminations adhering to successful world-first aviator. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Percentage. Reform of the EU pharmaceutical legalisation. European Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Compensation styles to attack market breakdowns for antimicrobials: strategies consumed France, Germany, Sweden, the United Kingdom, as well as the United States. Wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Alliance of Drug Manufacturers and also Affiliations. From protection to resilience: what could the future antibiotic pipeline seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Hub &amp Planet Health Company. Incentivising the advancement of brand new antibacterial treatments: 2023 progress report by the Global AMR R&ampD Hub and WHO. Global AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Vocalist, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK membership model for prescription antibiotics taken into consideration prosperous? Lancet Germ 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimulations for the development and also going on the market place of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, and nationwide reasons for child death in 2000\u00e2 $ \"13, along with forecasts to notify post-2015 concerns: an updated methodical review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial drug shortages from 2001 to 2013: ramifications for professional practice. Clin. Affect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for medicine shortages: description as well as styles from 2012 to 2018: an observational retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Assessment of that antibiotic intake and accessibility intendeds in 76 countries, 2000\u00e2 $ \"15: an analysis of pharmaceutical sales information. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Fighting the phonies: dealing with subpar as well as falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring much easier to obtain prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nAfrican Community for Research Laboratory Medication. Plan brief and also infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic usage for human make use of in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Med. Corrupt. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial consumption: study of core storehouses materials to in-patient care health amenities coming from 2017 to 2019 in Uganda. Trop. Med. Contaminate. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Variants in the usage of antimicrobial medicines in the European region, 2014\u00e2 $ \"2018: findings as well as effects from ESAC-Net as well as WHO Europe. Face. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et al. Drug shortage: triggers, influence, as well as mitigation techniques. Front. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Individual access in 14 high-income nations to new antibacterials authorized due to the United States Fda, European Medicines Agency, Japanese Pharmaceuticals as well as Medical Gadget Organization, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et cetera. Forgotten anti-biotics: a follow-up supply study in Europe, the USA, Canada and also Australia. Int. J. Antimicrob. Brokers 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness development for worldwide wellness. Br. Medication. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Business Alliance. The 2023 AMR Market Alliance progress study: production and also the setting. amr Market Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can clinical items be created on a non-profit basis? Exploring item progression partnerships for forgotten conditions. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et cetera. Reboot biomedical R&ampD in the worldwide public passion. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Ailment Control as well as Protection. Africa CDC initiates bold move to safeguard Africa\u00e2 $ s health future through producing a 50 billion dollar health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Blood, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Working out public-health patent licensing arrangements to increase accessibility to wellness innovations: an insider\u00e2 $ s story. BMJ Chunk. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New service designs for r &amp d along with cost demands are required to attain fair rates of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Gas. Stewardship as well as gain access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Anti-biotic Trial And Error Relationship. Shinogi, GARDP as well as CHAI reveal landmark license and also collaboration deals to handle bacterial infections next to expanding access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Partnership. Leaving behind the laboratory: tracking the decline in AMR R&ampD specialists. amr Market Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 contact us to activity on antimicrobial protection. G7G20 Papers Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Global Union on Growing Old &amp Contagious Diseases Society of United States. 2024 AMR preparedness index report card. Evaluating authorities action on AMR plan. Worldwide Coalition on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Meals as well as Farming Association of the United Nations, United Nations Environment Program, World Health Organization &amp. Planet Organization for Animal Health. International database for tracking antimicrobial resistance (AMR): country self-assessment study (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in th...

Integrating liver endpoints in clinical trials of cardiovascular and also renal ailment

.Nature Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint ask...

FALSE:: ERROR: UNSUPPORTED ENCODING...

Artificial knowledge directed testing for cardiomyopathies in an obstetric populace: a pragmatic randomized clinical test

.Trial style and oversightThe Screening for PEripartum Cardiomyopathies along with Artificial Intell...

Sustained HIV remission after allogeneic hematopoietic stem tissue transplantation along with wild-type CCR5 contributor cells

.Attribute Medicine, Published online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remissio...

Senolytics target mobile senescence-- but can they reduce getting older?

.In the 1960s, US anatomist Leonard Hayflick noticed that replicative cells have a minimal number of...